Literature DB >> 16542256

Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers.

Yingye Zheng1, Tianxi Cai, Ziding Feng.   

Abstract

The rapid advancement in molecule technology has led to the discovery of many markers that have potential applications in disease diagnosis and prognosis. In a prospective cohort study, information on a panel of biomarkers as well as the disease status for a patient are routinely collected over time. Such information is useful to predict patients' prognosis and select patients for targeted therapy. In this article, we develop procedures for constructing a composite test with optimal discrimination power when there are multiple markers available to assist in prediction and characterize the accuracy of the resulting test by extending the time-dependent receiver operating characteristic (ROC) curve methodology. We employ a modified logistic regression model to derive optimal linear composite scores such that their corresponding ROC curves are maximized at every false positive rate. We provide theoretical justification for using such a model for prognostic accuracy. The proposed method allows for time-varying marker effects and accommodates censored failure time outcome. When the effects of markers are approximately constant over time, we propose a more efficient estimating procedure under such models. We conduct numerical studies to evaluate the performance of the proposed procedures. Our results indicate the proposed methods are both flexible and efficient. We contrast these methods with an application concerning the prognostic accuracies of expression levels of six genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542256     DOI: 10.1111/j.1541-0420.2005.00441.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  29 in total

1.  On longitudinal prediction with time-to-event outcome: Comparison of modeling options.

Authors:  Marlena Maziarz; Patrick Heagerty; Tianxi Cai; Yingye Zheng
Journal:  Biometrics       Date:  2016-07-20       Impact factor: 2.571

2.  Evaluating the ROC performance of markers for future events.

Authors:  Margaret S Pepe; Yingye Zheng; Yuying Jin; Ying Huang; Chirag R Parikh; Wayne C Levy
Journal:  Lifetime Data Anal       Date:  2007-12-07       Impact factor: 1.588

3.  Comparing costs associated with risk stratification rules for t-year survival.

Authors:  Tianxi Cai; Lu Tian; Donald M Lloyd-Jones
Journal:  Biostatistics       Date:  2011-03-16       Impact factor: 5.899

4.  Treatment selections using risk-benefit profiles based on data from comparative randomized clinical trials with multiple endpoints.

Authors:  Brian Claggett; Lu Tian; Davide Castagno; Lee-Jen Wei
Journal:  Biostatistics       Date:  2014-08-12       Impact factor: 5.899

5.  Risk of fire occurrence in arid and semi-arid ecosystems of Iran: an investigation using Bayesian belief networks.

Authors:  Hossein Bashari; Ali Asghar Naghipour; Seyed Jamaleddin Khajeddin; Hamed Sangoony; Pejman Tahmasebi
Journal:  Environ Monit Assess       Date:  2016-08-23       Impact factor: 2.513

6.  Metabolic Tumor Volume in Lymphoma: Hype or Hope?

Authors:  Heiko Schöder; Craig Moskowitz
Journal:  J Clin Oncol       Date:  2016-10-20       Impact factor: 44.544

7.  The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy.

Authors:  Ilhan Lim; Woo Chul Noh; Jihyun Park; Ji Ae Park; Hyun-Ah Kim; Eun-Kyu Kim; Ko Woon Park; Seung Sook Lee; Eun Young You; Kyeong Min Kim; Byung Hyun Byun; Byung Ii Kim; Chang Woon Choi; Sang Moo Lim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-14       Impact factor: 9.236

8.  A two-stage approach for dynamic prediction of time-to-event distributions.

Authors:  Xuelin Huang; Fangrong Yan; Jing Ning; Ziding Feng; Sangbum Choi; Jorge Cortes
Journal:  Stat Med       Date:  2016-01-07       Impact factor: 2.373

9.  Regularized estimation for the accelerated failure time model.

Authors:  T Cai; J Huang; L Tian
Journal:  Biometrics       Date:  2009-06       Impact factor: 2.571

10.  The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.

Authors:  M Talieri; L Li; Y Zheng; D K Alexopoulou; A Soosaipillai; A Scorilas; D Xynopoulos; E P Diamandis
Journal:  Br J Cancer       Date:  2009-04-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.